FINHUB Insights

Elevance Health Q4 FY25: where the revenue came from and where it went

The whole income statement of Elevance Health for this quarter, as one diagram: what earned the revenue, and what it went on.

Period
Oct 1 – Dec 31, 2025
Reported
Feb 6, 2026 10-K accession 0001156039-26-000013

Revenue$49.75B +10% year over year
Gross profit$44.23B 89% margin
Operating profit$0.31B 1% margin
Net profit$0.55B 1% margin

Net profit is larger than what operations earned, because the statement adds $0.33B below it, under Tax benefit.

100% free

It's free. All of it.

A free account opens every diagram. We send one link to confirm your address, and that is the whole of it.

Already have an account? Sign in

The numbers

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
ItemValueShare of revenueYear over year
Revenue 49.75 100% +10%
Cost of revenue−5.5211%
Gross profit44.2389% margin+2pp
SG&A−5.4211%+0pp
Other−38.5077%
Operating profit0.311% margin−1pp
Interest & other costs−0.09
Tax benefit0.33
Net profit0.55 1% margin+0pp

Source of the numbers: the totals in the filing, whose revenue split this site could not read (10-K). The diagram is generated automatically and checked against EDGAR before release. The fourth quarter has no column of its own in an annual report, so it is the full year minus the first nine months. How we calculate it → About and methodology.

326 of 418 companies, most recently reported first